ES2174632T3 - Derivados de beta-carbolina hipnotica, procedimiento para su preparacion y su utilizacion como productos medicinales. - Google Patents

Derivados de beta-carbolina hipnotica, procedimiento para su preparacion y su utilizacion como productos medicinales.

Info

Publication number
ES2174632T3
ES2174632T3 ES99939844T ES99939844T ES2174632T3 ES 2174632 T3 ES2174632 T3 ES 2174632T3 ES 99939844 T ES99939844 T ES 99939844T ES 99939844 T ES99939844 T ES 99939844T ES 2174632 T3 ES2174632 T3 ES 2174632T3
Authority
ES
Spain
Prior art keywords
alkyl
radical
alkylcarbonylamino
halo
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99939844T
Other languages
English (en)
Inventor
Jean-Bernard Fourtillan
Marianne Fourtillan
Jean-Claude Jacquesy
Marie-Paule Jouannetaud
Bruno Violeau
Omar Karam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Macef SAS
Laboratoires Besins International SAS
Original Assignee
Macef SAS
Laboratoires Besins International SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/042,990 external-priority patent/US6048868A/en
Application filed by Macef SAS, Laboratoires Besins International SAS filed Critical Macef SAS
Application granted granted Critical
Publication of ES2174632T3 publication Critical patent/ES2174632T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Anesthesiology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Derivados de fórmula general Ia (Ia¿ y Ia¿¿): en las que R2 representa un hidroxilo o un radical alcoxi (C1-C6), R3 representa un átomo de hidrógeno o un radical alquil, siendo R6 un radical alquil, opcionalmente sustituido por alquil, haluro, amino, grupos alquiloxi, alquiloxicarbonil, un grupo fenil o piridil opcionalmente sustituido por un grupo alquil, haluro, nitro, dialquilamino, alquiloxi, alquiloxicarbonil, alquilamino, X representa preferentemente un radical divalente de fórmula R11 representa preferentemente un átomo de oxígeno o un átomo de azufre, R14 y R15 representan, independientemente uno de otro, un átomo de hidrógeno, un radical alquil (C1-C6), un cicloalquil (C3-C6), halo alquil (C1-C6), perhaloalquil (C1- C6), aril, aralquil, alcoxi (C1-C6), cicloalcoxi (C3-C6), mono o polihaloalcoxi, ariloxi, aralquiloxi, hidroxialquil, alquiloxialquil, alquiltio (C1-C6), cicloalquiltio (C3-C6), mono o polihaloalquiltio, ariltio, aralquiltio, formato, alquilcarboniloxi (C1-C6), un cicloalquilcarboniloxi (C3-C6), haloalquilcarboniloxi (C1-C3), arilcarboniloxi, aralquilcarboniloxi, dialquilaminoalquil, dialquilamino, diarilamino, diaralquilamino, carboxamida opcionalmente sustituída, formamida, un alquilcarbonilamino (C1-C6), un cicloalquilcarbonilamino (C3-C6), halo alquilcarbonilamino (C1-C6), perhalo alquilcarbonilamino (C1-C6), arilcarbonilamino (C3-C6), aralquilcarbonilamino (C1-C6), formil, un alquilcarbonil (C1-C6), un cicloalquilcarbonil (C3-C6), haloalquilcarbonil (C1-C6), perhaloalquilcarbonil (C1-C6), arilcarbonil, aralquilcarbonil, carboxil, alcoxicarbonil (C1-C6), cicloalcoxicarbonil (C3-C6), haloalcoxicarbonil, ariloxicarbonil, aralquiloxicarbonil, un alquilsulfonil (C1-C6), un cicloalquilsulfonil (C3-C6), haloalquilsulfonil (C1-C6), perhaloalquilsulfonil (C1-C6), arilsulfonil, aralquilsulfonil, radical halo, ciano o nitro.
ES99939844T 1998-03-17 1999-03-17 Derivados de beta-carbolina hipnotica, procedimiento para su preparacion y su utilizacion como productos medicinales. Expired - Lifetime ES2174632T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/042,990 US6048868A (en) 1994-09-14 1998-03-17 Melatonin-antagonist β-carboline derivatives and analogues thereof containing naphthalenic structure, process for their preparation and their use as medicinal products

Publications (1)

Publication Number Publication Date
ES2174632T3 true ES2174632T3 (es) 2002-11-01

Family

ID=21924862

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99939844T Expired - Lifetime ES2174632T3 (es) 1998-03-17 1999-03-17 Derivados de beta-carbolina hipnotica, procedimiento para su preparacion y su utilizacion como productos medicinales.

Country Status (24)

Country Link
EP (1) EP1064284B1 (es)
JP (1) JP4333036B2 (es)
CN (1) CN1115342C (es)
AR (1) AR018767A1 (es)
AT (1) ATE215087T1 (es)
AU (1) AU752364B2 (es)
BG (1) BG63973B1 (es)
BR (1) BR9908833A (es)
CA (1) CA2324270A1 (es)
DE (1) DE69901098T2 (es)
DK (1) DK1064284T3 (es)
ES (1) ES2174632T3 (es)
HU (1) HUP0101234A3 (es)
IL (1) IL138442A (es)
IS (1) IS2199B (es)
NO (1) NO317296B1 (es)
NZ (1) NZ506913A (es)
PL (1) PL193450B1 (es)
PT (1) PT1064284E (es)
RU (1) RU2210571C2 (es)
SK (1) SK284387B6 (es)
TR (1) TR200003596T2 (es)
UA (1) UA71911C2 (es)
WO (1) WO1999047521A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2824829B1 (fr) 2001-05-16 2005-06-03 Macef Nouveaux derives de dihydroimidazo [5,1-a]-beta-carboline, leur procede de preparation et leur application a titre de medicament
FR2904973A1 (fr) * 2006-08-18 2008-02-22 Fourtillan Snc Derives de 1-methylidene-pyrido[3,4-b]indole et leur utilisation en therapeutique.
FR2916200A1 (fr) * 2007-05-18 2008-11-21 Fourtillan Snc Nouveaux derives des 1,2,3,4,6,7,12,12a-octahydro pyrazino[1',2':1,6]pyrido[3,4-b]indoles, leur preparation et leur utilisation en therapeutique
EP2240481A1 (en) 2008-01-11 2010-10-20 Albany Molecular Research, Inc. (1-azinone) -substituted pyridoindoles as mch antagonists
US9073925B2 (en) 2009-07-01 2015-07-07 Albany Molecular Research, Inc. Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
WO2011003007A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
JP2012532144A (ja) 2009-07-01 2012-12-13 アルバニー モレキュラー リサーチ， インコーポレイテッド アジノン置換アゼピノ［ｂ］インドールおよびピリド−ピロロ−アゼピンｍｃｈ−１拮抗薬、ならびにその作製方法および使用
US8618299B2 (en) 2009-07-01 2013-12-31 Albany Molecular Research, Inc. Azinone-substituted azapolycycle MCH-1 antagonists, methods of making, and use thereof
US8993765B2 (en) 2010-12-21 2015-03-31 Albany Molecular Research, Inc. Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof
WO2012088038A2 (en) 2010-12-21 2012-06-28 Albany Molecular Research, Inc. Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
FI130627B (en) * 2021-03-31 2023-12-18 Equinorm Ltd NEW HETEROCYCLIC COMPOUNDS AND THEIR USE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283343A (en) * 1987-08-17 1994-02-01 Whitby Research, Inc. 2-aryl substituted N-acetyltryptamines and process of preparing such
FR2724384B1 (fr) * 1994-09-14 1999-04-16 Cemaf Nouveaux derives de la 3,4-dihydro beta-carboline agonistes de la melatonine, leur procede de preparation et leur utilisation a titre de medicament

Also Published As

Publication number Publication date
RU2210571C2 (ru) 2003-08-20
BG63973B1 (bg) 2003-08-29
PT1064284E (pt) 2002-09-30
SK284387B6 (sk) 2005-02-04
NZ506913A (en) 2003-07-25
CA2324270A1 (en) 1999-09-23
ATE215087T1 (de) 2002-04-15
DE69901098D1 (de) 2002-05-02
IL138442A0 (en) 2001-10-31
EP1064284A1 (en) 2001-01-03
AR018767A1 (es) 2001-12-12
HUP0101234A2 (hu) 2001-12-28
IS5627A (is) 2000-09-12
EP1064284B1 (en) 2002-03-27
UA71911C2 (en) 2005-01-17
DK1064284T3 (da) 2002-07-22
NO317296B1 (no) 2004-10-04
IS2199B (is) 2007-02-15
IL138442A (en) 2006-12-10
HUP0101234A3 (en) 2002-12-28
AU3270799A (en) 1999-10-11
NO20004638L (no) 2000-11-16
CN1115342C (zh) 2003-07-23
WO1999047521A1 (en) 1999-09-23
NO20004638D0 (no) 2000-09-15
BG104768A (en) 2001-05-31
PL193450B1 (pl) 2007-02-28
DE69901098T2 (de) 2002-11-21
PL342929A1 (en) 2001-07-16
JP4333036B2 (ja) 2009-09-16
SK13852000A3 (sk) 2001-09-11
CN1299361A (zh) 2001-06-13
JP2002506867A (ja) 2002-03-05
AU752364B2 (en) 2002-09-19
TR200003596T2 (tr) 2001-04-20
BR9908833A (pt) 2000-11-21

Similar Documents

Publication Publication Date Title
ES2174632T3 (es) Derivados de beta-carbolina hipnotica, procedimiento para su preparacion y su utilizacion como productos medicinales.
AR009811A1 (es) Compuestos herbicidas, proceso para su produccion, proceso para la produccion de intermediarios, compuestos intermediarios para su exclusivo usoen dicho proceso, composicion que tiene actividad herbicida selectiva y proceso para el control selectivo de malas hierbas y gramineas en cultivos de planta
IL85659A (en) 4-benzoylpyrazole derivatives,method for their preparation and herbicidal compositions containing them
PE20030062A1 (es) Derivados aralquilsulfonil-3-(pirrol-2-ilmetiliden)-2-indolinona como inhibidores de quinasas
RS20060315A (en) Derivatives of n-/phenyl(pyrrolidine-2-yl) methyl/benzamide, and n- /(azepan-2-yl)phenylmethyl/benzamide, preparation method thereof and application of same in therapeutics
CO6241157A2 (es) "derivados de 6-(pirrolidin-3-il)-1h-pirazolo{3,4-d}pirimidin-4(5h)-ona utiles como inhibidores de pde9"
ES2186354T3 (es) Uso de dihidropirimidinas como medicamentos y nuevas sustancias para el tratamiento de hepatitis b.
DE69613860D1 (de) Pyrazol-derivate, verfahren für ihre herstellung und sie enthaltende zusammensetzungen
CO6270320A2 (es) Derivados de piperidina utiles como antagonistas del receptor orexina
AR049418A1 (es) Derivados de heteroarilaminopirazol y composiciones farmaceuticas para el tratamiento de la diabetes.
ES2531149T3 (es) Derivados de 2-piridiniletilcarboxamida y su uso como fungicidas
AR067327A1 (es) Derivados de piperidina / piperazina
MX2007003872A (es) Nuevos derivados bis-azaindolicos, preparacion y su uso farmaceutico de los mismos como inhibidores de cinasas.
FI883669A0 (fi) 1-/(4-piperidinyl) metyl/ -1,2,3,4-tetrahydro-9h-pyrido/3.4-b/ indolderivat, deras framstaellning och terapeutiska anvaendning.
CO4920225A1 (es) 2-amino-6-(4-fenoxi-2-sustituido)-piridinas sustituidas
PL327466A1 (en) Novel derivatives of barbituric acid, method of obtaining them and pharmaceutic agents containing such compounds
MXPA02012073A (es) 2-(cianoamino)pirimidinas substituidas con 5-fenilo fungicidas.
DE69317439T2 (de) Azoxycyanbenzol-Derivate
MXPA06001039A (es) Derivados de nicotinamida utiles como inhibidores de pde4.
CO5050264A1 (es) Derivados de 6-azauracilo como inhibidores il-5 procedimientos para su preparacion y composiciones farmaceuticas que comprenden dichos derivados
AR083861A1 (es) OXAZOLIDINONAS COMO MODULADORES DE mGluR5 Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN
EA200400867A3 (ru) Новые соединения гетероциклического оксима, способ их получения и фармацевтические композиции, содержащие их
AR062113A1 (es) Derivados de eteres heterociclicos sustituidos,composiciones farmaceuticas que los contienen y usos en trastornos del cns.
AR031808A1 (es) 2-piridonas antimicrobianas, sus composiciones y usos
CO5080793A1 (es) Productos derivados de las sulfonamidas

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 1064284

Country of ref document: ES